Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Alberta

$90,000.00

The Metabolic Basis of Right Ventricular Failure

FY 2011-12

Summary
Failure of the heart muscle to pump blood through the body is a major cause of death throughout the world. Although the heart has two equally important chambers, the right ventricle and the left ventricle, almost all of the efforts of the medical and research communities to treat heart failure focus on the left ventricle. We now recognize critical differences between the two heart chambers and we cannot extrapolate findings from one to the other. The right ventricle of the heart fails more frequently than the left ventricle does, and in several common diseases and conditions associated with high death rates. There are currently no therapies designed specifically to improve the function of the right chambers of the heart. The specific hypothesis pursued is that one of the reasons that the right ventricle fails more easily than the left ventricle is that as it thickens in response to disease process, it cannot keep up with the generation of new blood vessels to supply the growing muscle with more blood. This is called suppressed angiogenesis. We specifically propose that the basis for this suppressed angiogenesis is a unique metabolic environment in the right compared to the left myocardium, in other words that there are key differences in how the fueling of the two chambers is regulated. We believe that this unique metabolic environment is caused by circulating factors that reflect a more generalized disturbance in patients with failing right chambers. Measuring these circulating factors in the blood may allow us to predict failure of the right chambers on time and more importantly show us ways that we could actually prevent it. We propose to study this hypothesis in both animals and patients with standard and novel techniques and cutting edge equipment. Our work may offer for the first time ways to predict right ventricular failure and identify for the first time much needed therapies that are specific to the right ventricle.
Program
CIHR Fellowship
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
242560
Name
Paulin Roxane V
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The Metabolic Basis of Right Ventricular Failure
Programtype2
Fellowship Programs
Orgnameinp2
University of Alberta
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Angiogenesis; Biomarkers; Hypertrophy/Failure Transition; Metabolism; Micorna Signature; Right Ventricle; Translational Approach
Abstract
Failure of the heart muscle to pump blood through the body is a major cause of death throughout the world. Although the heart has two equally important chambers, the right ventricle and the left ventricle, almost all of the efforts of the medical and research communities to treat heart failure focus on the left ventricle. We now recognize critical differences between the two heart chambers and we cannot extrapolate findings from one to the other. The right ventricle of the heart fails more frequently than the left ventricle does, and in several common diseases and conditions associated with high death rates. There are currently no therapies designed specifically to improve the function of the right chambers of the heart. The specific hypothesis pursued is that one of the reasons that the right ventricle fails more easily than the left ventricle is that as it thickens in response to disease process, it cannot keep up with the generation of new blood vessels to supply the growing muscle with more blood. This is called suppressed angiogenesis. We specifically propose that the basis for this suppressed angiogenesis is a unique metabolic environment in the right compared to the left myocardium, in other words that there are key differences in how the fueling of the two chambers is regulated. We believe that this unique metabolic environment is caused by circulating factors that reflect a more generalized disturbance in patients with failing right chambers. Measuring these circulating factors in the blood may allow us to predict failure of the right chambers on time and more importantly show us ways that we could actually prevent it. We propose to study this hypothesis in both animals and patients with standard and novel techniques and cutting edge equipment. Our work may offer for the first time ways to predict right ventricular failure and identify for the first time much needed therapies that are specific to the right ventricle.
Competitiondate
201110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Paulin, Roxane V
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~
University of Alberta - $90,000 Grant (2011-12) | Canada Spends